New treatments

First Alzheimer’s drug authorised in Switzerland

This content was published on Feb 4, 2026 Swissmedic authorises first drug to slow down the progression of Alzheimer's disease.

New treatments

Science podcast: the AI revolution in drug development

This content was published on Jan 30, 2026 In episode 4 of the Swiss Connection Science podcast we explore the role of AI in drug development.

Roche achieves research success with novel fat-lowering agent

New treatments

Roche reports positive results for experimental obesity drug

This content was published on Jan 27, 2026 Roche says that a phase II clinical trial of its experimental obesity drug CT-388 has given positive results.

New treatments

Science podcast: Can gender diversity create better medicine?

This content was published on Jan 23, 2026 In episode 3 of this season's Swiss Connection science podcast we look at the role of sex and gender in drug development.

New treatments

Science podcast: cracking the Alzheimer’s code

This content was published on Jan 16, 2026 In episode 2 of the Swiss Connection science podcast, we explore the latest treatments for Alzheimer's disease.

New treatments

Science podcast: Are longevity clinics the key to healthy ageing?

This content was published on Jan 9, 2026 Explore the latest breakthroughs in longevity in episode 1 of this season's Swiss Connection science podcast.

Pharma supply chains

Vaccine maker Janssen closes plant in Bern

This content was published on Dec 31, 2025 Janssen to close Bern vaccine plant by 2026, with job cuts and a planned site sale.

New treatments

Desperate to save their children, parents become unexpected drug developers

This content was published on Dec 18, 2025 As the pharma industry turns away, parents of children with ultra-rare diseases step in to advance drug development.